Hospital Hm Nou Delfos
- Address
- lock Available on a paid plan
Musculoskeletal Diseases
Research at Hospital Hm Nou Delfos focuses on musculoskeletal conditions, aiming to improve pain management and functional outcomes.
- Knee osteoarthritis pain
- Diabetic peripheral neuropathic pain
These studies test therapeutic agents designed to reduce discomfort and enhance mobility for patients with joint and nerve‑related pain.
Neoplasms
The oncology department conducts extensive investigations into cancers, seeking safer and more effective treatments.
- Advanced solid tumors with KRASG12C mutation
- HER2‑positive breast and lung cancers
- Head and neck squamous cell carcinoma
- Metastatic solid malignancies
Trials evaluate novel antibodies, targeted inhibitors, and combination regimens to halt tumor growth and improve survival rates.
Nervous System Diseases
Studies at the site also address disorders of the nervous system, concentrating on chronic pain syndromes linked to nerve damage.
- Diabetic peripheral neuropathic pain
- Neuropathic pain in solid tumor patients
- Head and neck squamous cell carcinoma with neurological involvement
The goal is to assess safety and efficacy of emerging analgesic compounds, offering hope for better quality of life.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 9 therapeutic areas and 15 of 82 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 74 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 52 by active trials.
- 1BioNTech SE3active
lock +51 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +16 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hospital Hm Nou Delfos
lock Showing 1 of 97 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A multicenter randomized, double-blind, placebo-controlled Phase 2 study to evaluate efficacy, safety, tolerability, pharmacokinetics and target engagement of GSK3858279 in adult participants with chronic Diabetic Peripheral Neuropathic Pain (DPNP) / NEPTUNE-17. | Glaxosmithkline Research & Development Limited | Phase II | Not Recruiting | Dec 2023 | Oct 2024 |
IMP list
lock Showing 1 of 82 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pembrolizumab | 10 | Unknown | 2019-10-01 | 2026-07-07 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.